|3/20/2018||Orion Corporation: Organising meeting of the Board of Directors|
|3/20/2018||Orion Corporation: Decisions by the AGM on 20 March 2018|
|3/1/2018||Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018|
|2/26/2018||Orion Group Financial Statement documents 2017 and Corporate Governance Statement published|
|4/10/2018||Publishing of Orion Corporation's Interim Report for January-March 2018 on 24 April 2018|
|4/3/2018||Status update of the Phase III ARAMIS clinical trial with darolutamide in patients with non-metastatic castration-resistant prostate cancer|
|3/19/2018||Orion has received positive conclusions for the salmeterol-fluticasone Easyhaler® combination under the EU's decentralized procedures|
|2/28/2018||Orion's statutory co-operation negotiations completed|
As the cost pressures on pharmaceutical companies increase, Orion needs to constantly improve its efficiency to stay competitive. In 2016, the company began a group-wide Lean program, where the entire staff is involved in a culture of continuous improvement. Orion’s shift toward Lean culture received the Lean Prize 2016 from Lean Association of Finland.
11 January 2017 | On 1st November 2016 the Innovative Medicines Initiative (IMI) together with an association of industrial partners came together to support PHAGO, an innovative research project devoted to the development of immunomodulatory therapies for Alzheimer’s disease (AD).